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Artificial Intelligence and Technology in Health Care:
Overview and Possible Legal Implications
Sarah Kamensky*
I. Introduction
The chief concerns in the health care system in the United States today are cost, quality,
and access to care.1 In an effort to improve our health care system, innovators have begun to
develop technology and artificial intelligence to aid in reaching these goals.2 In a health care
setting, artificial intelligence can be used to improve the efficiency and quality of patient care, as
well as advancing medical research.3 Today, approximately 86% of health care providers utilize
at least one form of artificial intelligence in their practices. However, under traditional tort liability
it remains unclear as to the possible legal implications and liability in the event of medical error
involving artificial intelligence technology.4 The use of artificial intelligence technology in a
medical setting will inevitably create risks since not all of the possible consequences of the use of
the new technology are foreseeable.5 There is currently limited information as to legal implications
for tort liability for error involving artificial intelligence in medical settings since both the

*Sarah Kamensky is a third-year law student at DePaul University College of Law and will receive her J.D. Degree
in May of 2020. She will receive a certificate in Health Law upon graduation and is currently a member of the
DePaul Journal of Health Care Law.
1
Concerns over improving the cost, quality, access, and choice of care are increasingly reflected in today’s health
care systems in the United States. Ongoing attempts to reform health care systems have focused on these concepts,
while transforming health care delivery and payment systems with the aim of meeting these goals. BARRY R.
FURROW ET AL., HEALTH LAW: CASES, MATERIALS, AND PROBLEMS 1 (W. Acad. Publ’g, 8th ed. 2018); see also
How AI-based Systems Can Improve Medical Outcomes, KNOWLEDGE@WHARTON (Dec. 12, 2018),
http://knowledge.wharton.upenn.edu/article/ai-based-systems-can-improve-medical-outcomes/.
2
Hannah R. Sullivan & Scott J. Schweikart, Are Current Tort Liability Doctrines Adequate for Addressing Injury
Caused by AI?, 21 AMA J. ETHICS 160, 160 (2019).
3
W. Nicholson Price II, Artificial Intelligence in Health Care: Applications and Legal Implications, 14
SCITECHLAW 10, 10 (2017).
4
Sullivan & Schweikart, supra note 2, at 160, 162, 164.
5
Chris Reed, How Should we Regulate Artificial Intelligence?, ROYAL SOC’Y PUBL’G, Apr. 29, 2018, at 1
https://royalsocietypublishing.org/doi/pdf/10.1098/rsta.2017.0360.

technology and usage are still developing themselves; however, traditional tort liability laws may
be applicable.6

II. Overview
Today, highly intelligent machines and sophisticated robots are performing complex tasks
that were once thought to only be within the exclusive ability of humans.7 This partnership of
humans with technology is being realized in many tangible ways and is evident in health care
settings today through the use of artificial intelligence technology in providing patient care.8 In
general, artificial intelligence uses technology, along with programmed computer systems, to
accomplish specific tasks by processing large amounts of data and recognizing patterns within the
data.9 This form of technology makes it possible for machines to “learn from experience” so that
they can perform human-like tasks.10 In a health care setting, artificial intelligence refers to the
use of artificial intelligence technology and automated processes to diagnose and treat patients
who require care.11 Artificial intelligence relies on the power of predictive algorithms, which
guide health care professionals in their practice of medicine.12
The mechanisms that give rise to the recommendations made by the predictive algorithms
are currently undiscoverable and unknown due to the way that the algorithms calculate their

6

Sullivan & Schweikart, supra note 2, at 160 (explaining that given the limited information regarding tort liability
involving artificial intelligence in medicine, traditional tort liability laws may be applicable. “Liability for medical
errors falls under tort law. A tort is a civil claim in which a party requests damages for injuries caused by a harmful,
wrongful act of another. Typical tort claims in the realm of medicine and health include medical malpractice
(negligence), respondeat superior (vicarious liability), and products liability.”).
7
David C. Vladeck, Machines Without Principals: Liability Rules and Artificial Intelligence, 89 WASH. L. REV.
117, 120 (2014).
8
Id. at 118.
9
Jim Goodnight, Artificial Intelligence: What it is and why it matters, SAS,
https://www.sas.com/en_us/insights/analytics/what-is-artificial-intelligence.html (last visited Mar. 8, 2020).
10
Id.
11
Artificial Intelligence in Medicine, MENDELEY (July 2, 2018),
https://www.mendeley.com/careers/article/artificial-intelligence-in-medicine/.
12
Sullivan & Schweikart, supra note 2, at 160.

2

“reasoning”.13 This is often referred to as “black-box” artificial intelligence.14 The “neural
networks” behind the algorithms in black-box artificial intelligence are structured based on the
human brain, so that the neural networks can self-teach, make decisions, and provide accurate
responses.15 Despite the ability of this technology to provide accurate responses, and aid in
improving the cost, access, and quality of patient care, the algorithms by which the technology
operates have the potential to “become less intelligible to users and even the developers who
originally programmed the technology.”16 This means that the artificial intelligence technology
will not be able to demonstrate how it formed its conclusions.17 This can become problematic in
a medical setting since artificial intelligence cannot explain its decision-making process in the
same way that a physician or health care provider would.18 Even if the algorithm can give some
explanation as to how the technology came to its conclusion, it will likely not have a useful
meaning in medical terms.19 Additionally, the algorithms will become even more complex when
more data is made available, which refines future predictions made by the algorithms, but also
causes the algorithms to change over time.20

13

Id.
Id.; see also W. Nicholson Price II, Black-Box Medicine, 28 HARV. J.L. & TECH. 419, 421 (2015).
15
Sullivan & Schweikart, supra note 2, at 160.
16
Id. at 160–61; see also Shailin Thomas, Artificial Intelligence and Medical Liability (Part II), BILL HEALTH (Feb.
10, 2017), http://blog.petrieflom.law.harvard.edu/2017/02/10/artificial-intelligence-and-medical-liability-part-ii/.
17
Price, supra note 3.
18
Id. at 11.
19
Id. at 10 (explaining that either algorithms cannot explain their outcomes at all, or accurate explanations can be
provided that will be useless in medical understanding. This field is referred to as “black-box medicine,” although it
has also been referred to as “predictive analytics” or “AI in medicine” due to the inherent opacity of the technology.
The inherent opacity of the algorithms may or may not be “augmented with deliberate secrecy” based on how the
algorithms were developed and validated).
20
Id.
14
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III. Artificial Intelligence and Black-Box Medicine
Artificial intelligence technology in the form of “black-box” medicine is already being
utilized in health care systems in many capacities, and has the potential to provide substantial
benefits to patients.21 These automated processes not only aid in the diagnosis and treatment of
patients, but also are gaining importance in the background processes that must take place in order
for a patient to be properly treated.22 Arguments have been made that the use of these forms of
technology allow tasks to be completed more quickly, while also allowing health care providers to
treat patients more efficiently.23
Artificial intelligence is currently being used to process and analyze patients’ test results,
gather data through patient interviews, use data to determine appropriate diagnoses, and to present
options for treatment methods while also monitoring patients after suitable treatments have been
administered.24

For example, a “decision support system” developed at the Laboratory of

Computer Science at the Massachusetts General Hospital, DXplain, offers the health care provider
a list of possible diagnoses after the symptoms are input in DXplain’s computer system.25 DXplain

Id.; see also Price, supra note 14, at 421 (“Black box medicine, pursued by geneticists, personalized medicine
advocates, and other health care innovators, already does and increasingly will use the combination of largescale
high-quality datasets with sophisticated predictive algorithms to identify and use implicit, complex connections
between multiple patient characteristics. A defining feature of black box medicine is that those algorithms are
nontransparent — that is, the relationships they capture cannot be explicitly understood, and sometimes cannot even
be explicitly stated. Note that this type of medicine is ‘black box’ to everyone by nature of its development; it is not
‘black box’ because its workings are deliberately hidden from view.”).
22
MENDELEY, supra note 11.
23
Id. (“The potential for increased AI usage in medicine is not just in a reduction of manual tasks and the freeing up
of physician’s time, increasing efficiency and productivity — it also presents the opportunity for us to move towards
more ‘precision medicine.’”).
24
Id.; see also Shailin Thomas, Artificial Intelligence, Medical Malpractice, and the End of Defensive Medicine,
BILL HEALTH (Jan. 26, 2017), http://blog.petrieflom.law.harvard.edu/2017/01/26/artificial-intelligence-medicalmalpractice-and-the-end-of-defensive-medicine/.
25
DXplain: Using Decision Support to Help Explain Clinical Manifestations of Disease, MASS. GEN. HOSP. LAB.
FOR COMPUT. SCI., http://www.mghlcs.org/projects/dxplain/ (last updated 2017) (“The current DXplain knowledge
base includes over 2400 diseases and over 5000 clinical findings (symptoms, signs, epidemiologic data and
laboratory, endoscopic and radiologic findings). The average disease description includes 53 findings, with a range
from 10 to over 100. Each disease/finding pair has two attributes describing the relationship: one representing the
frequency with which the finding occurs in the disease and the other the degree to which the presence of the finding
suggests consideration of the disease. There are over 230,000 individual data points in the knowledge base
21
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uses appropriate data to determine diagnoses by using its knowledge base of diseases and clinical
findings.26 This is an example of “machine learning techniques”, a subset of artificial intelligence,
that uses basic learning rules to find patterns in vast amounts of data.27
With the rise of vast quantities of data combined with the need to have fast access to the
data, medicine is now experiencing a need for technology and artificial intelligence containing
machine learning techniques in order to reach the above mentioned goals of improving the cost,
access, and quality of medical care.28 DXplain is just one example of a machine learning technique
currently used in medicine.29 A laboratory information system, Germwatcher, is another machine
learning technique currently used in medicine to “detect, track, and investigate infections in
hospitalized patients.”30
In addition to machine learning techniques, artificial intelligence is currently being used in
medicine in other forms such as robotic systems.31 One of the more common robotic systems
currently used in medicine is the da Vinci robotic surgical system.32 The robotic arms of the
surgical system allow surgeons to perform precise movements that would not be possible with an
entirely manual approach, thus allowing the quality of care in certain types of surgeries to be
improved by utilizing the da Vinci robotic surgical system.33

representing disease/finding relationships. In addition, each finding has an associated disease-independent term
importance indicating how important it is to explain the presence of the finding.”).
26
Id.
27
Price, supra note 3.
28
MENDELEY, supra note 11.
29
MASS. GEN. HOSP. LAB. FOR COMPUT. SCI., supra note 25.
30
MENDELEY, supra note 11.
31
Id.
32
About da Vinci Systems, INTUITIVE (2019), https://www.davincisurgery.com/da-vinci-systems/about-da-vincisystems (“The da Vinci System is powered by robotic technology that allows the surgeon’s hand movements to be
translated into smaller, precise movements of tiny instruments inside the patient’s body. One of the instruments is a
laparoscope — a thin tube with a tiny camera and light at the end. The camera sends images to a video monitor in
the operating room to guide doctors during surgery. The surgeon is 100% in control of the da Vinci System at all
times. The da Vinci System has brought minimally invasive surgery to more than 3 million patients worldwide.”).
33
Id.; see also MENDELEY, supra note 11.
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As illustrated by these specific examples, artificial intelligence already does aid in
improving the quality and access to health care, and has the potential to continue to provide
significant developments in the field of medicine; however, this substantial potential comes with
medical, technical, and legal challenges.34 Artificial intelligence in medicine must be safe and
effective, and the question becomes how to protect and provide recourse to patients while ensuring
the efficient development and continuing use of artificial intelligence technology in medicine.35

IV. Decision Making with Artificial Intelligence
Artificial intelligence and machine learning algorithms will continue to make significant
impacts in decision-making processes, diagnoses, and the treatment of patients in health care
systems.36 The connections of these algorithms with patient data allow health care providers to
“increase the precision and accuracy of their diagnoses and decisions” so that they are able to
identify illness and treat patients with more exactness and accuracy than ever before.37 According
to Shailin Thomas in Artificial Intelligence, Medical Malpractice, and the End of Defensive
Medicine, the introduction of artificial intelligence “to medical diagnosis and decision-making has
the potential to greatly reduce the number of medical errors and misdiagnoses – and allow
diagnosis based on physiological relationships we don’t even know exist.”38 However, predictions
based on the complex connections between a patient’s data and the recommended treatment are

34

Price, supra note 3.
Id.; see also Thomas, supra note 24.
36
Id.
37
Price, supra note 14 (explaining that this is also known as black-box medicine, “a version of personalized
medicine in which researchers use sophisticated algorithms to examine huge troves of health data, finding complex,
implicit relationships and making individualized assessments for patients. This new form of medicine offers
potentially immense benefits but faces major hurdles both in development and in application
. . . . [B]lack-box medicine also raises significant challenges with respect to privacy, regulation, and
commercialization.”).
38
Thomas, supra note 24.
35
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often given with little to no explanation.39 When such dependence in decision making is placed
on an algorithm, potential malpractice claims become complicated due to the reliance on artificial
intelligence and the lack of an explanation that it provides for its decisions.40 When a physician
pursues an improper diagnosis or treatment based on the reliance on artificial intelligence and
machine learning algorithms, it becomes somewhat unclear who should be responsible when an
error occurs.41

V. Current Tort Liability Laws Applied to Artificial Intelligence
Our current tort liability laws may not be sufficient to apply to medical error resulting from
decisions made by artificial intelligence.42 The main source of concern in determining liability for
these errors stems from the fact that we as humans cannot “see” the reasoning made by the artificial
intelligence technology.43 Questions then arise as to whether traditional products liability laws
should apply, holding the manufacturer of the technology liable, or if the health care provider
treating the patient by way of using artificial intelligence should be held liable for errors.44
Typically, liability for medical errors falls under a negligence framework. 45 Tort liability
law in general, including liability for medical errors, typically serves the purpose of compensating

39

Id.
Sullivan & Schweikart, supra note 2, at 160 (explaining that as capabilities of predictive algorithms improve,
“machine learning will become an important element of physician practice and patient care. Implementation of
artificial intelligence raises complex legal questions regarding health care professionals’ and technology
manufacturers’ liability, particularly if they cannot explain recommendations generated by AI technology.”).
41
Id.
42
Vladeck, supra note 7, at 121.
43
Vijay Pande, Artificial Intelligence’s ‘Black Box’ Is Nothing to Fear, N.Y. TIMES (Jan. 25, 2018),
https://www.nytimes.com/2018/01/25/opinion/artificial-intelligence-black-box.html (clarifying that artificial
intelligence cannot explain how it comes to its conclusions in the same way that a “human doctor would” when
making a diagnosis. For example, when a physician makes a diagnosis, he or she will be capable of explaining how
she reached that conclusion to the patient. If the same diagnosis were made using artificial intelligence, then it
would be a diagnosis made with “a direct connection to the data” rather than “human intuition based on limited
data.”).
44
Id.
45
Id.; see also Negligence, BLACK’S LAW DICTIONARY (10th ed. 2014) (defining negligence as “the failure to
exercise the standard of care that a reasonably prudent person would have exercised in a similar situation; any
40
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injured parties and deterring unreasonably dangerous conduct.46 Courts have typically enforced
the standards of practice that the medical profession sets through tort lawsuits.47 When there is a
case involving medical error, physician liability is determined based on the notion of the physician
as a trusted expert.48 This means that the treating physician is entirely accountable for his or her
decisions, and thus if the care provided is determined to be reckless or negligent, then the physician
will be held responsible.49
Standards also evolve over time based on advances in medical research and technology. In
judicial determinations for tort claims involving medical error, expert testimony relating to
customary practices in the specific field of medicine become important.50 While these standards
typically evolve through the practices of health care providers, the standard of care can also be
influenced by practice guidelines set in place by professional medical organizations or legislative
action.51 While artificial intelligence technology and machine learning algorithms currently used
in medicine are continuously developing, standards of care involving artificial intelligence are still

conduct that falls below the legal standard established to protect others against unreasonable risk of harm, except for
conduct that is intentionally, wantonly, or willfully disregardful of other’s rights; the doing of what a reasonable and
prudent person would not do under the particular circumstances, or the failure to what such a person would do under
the circumstances.”).
46
B. Sonny Bal, An Introduction to Medical Malpractice in the United States, 467 CLINICAL ORTHOPEDICS &
RELATED RES., 339, 340 (2009).
47
FURROW ET AL., supra note 1, at 218 (“Defendants trying to prove a standard of care normally present expert
testimony describing the actual pattern of medical practice without any reference to the effectiveness of that
practice. Courts have traditionally given professional medical standards conclusive weight so that the trier of fact is
not allowed to reject the practice as improper.”); see, e.g., Doe v. Am. Red Cross Blood Serv., 377 S.E.2d 323, 328
(S.C. 1989) (concluding that a medical professional cannot be found liable as a matter of law if the plaintiff cannot
demonstrate that the medical professional failed to conform to the generally recognized practices in his or her
profession).
48
Thomas, supra note 24.
49
Id.
50
Sullivan & Schweikart, supra note 2, at 160–61.
51
W. Nicholson Price II, Medical Malpractice and Black Box Medicine, at 9 (U. Mich. Pub. L. & Legal Theory Res.
Paper Series, Paper No. 536, 2017).
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evolving. Therefore, customs have not been established as they have been for more traditional
medical techniques and practices.52
Additionally, it becomes challenging to apply the current standards used to determine
physician liability in cases of error involving artificial intelligence technology when the error has
occurred due to the technology and not necessarily the physician.53 The algorithms used in the
artificial intelligence technology currently used in medicine are beginning to have higher accuracy
rates than physicians.54 Thus, it can become difficult to continue to solely hold the physician liable
and to apply a traditional negligence framework to medical error involving artificial intelligence
because the physician should not necessarily be blamed for following the algorithms and/or
artificial intelligence technology.55 However, the counterargument becomes that artificial
intelligence technology that is used primarily as an aid to health care providers in decision-making
allows the final decision in terms of diagnosis or treatment to always rest in the hands of the
provider.56 In these scenarios, traditional tort liability theories may be applicable since the decision
making will arguably be primarily made by the provider and not the artificial intelligence
technology.57
VI. Applying Current Legal Doctrines to Artificial Intelligence

52

Id.
Thomas, supra note 24 (explaining that if algorithms have “a higher accuracy rate than the average doctor — as
many soon will — it seems wrong to continue to place blame on the physician. Going with the algorithm’s
suggestion would always be statistically the best option — so it’s hard to argue that a physician would be negligent
in following the algorithm, even if it turns out to be wrong and the doctor ends up harming a patient. As algorithms
improve and doctors use them more for diagnosing and decision-making, the traditional malpractice notions of
physician negligence and recklessness may become harder to apply.”).
54
Id.
55
Id.
56
Vladeck, supra note 7, at 121.
57
Id.; see also Johan Ordish, Legal liability for machine learning in healthcare, PHG FOUND. (Aug. 2018)
https://www.phgfoundation.org/documents/briefing-note-legal-liability-for-machine-learning-in-healthcare.pdf (“If a
patient is harmed by a faulty diagnosis, the most obvious response is to sue the clinician, or most probably their
employer. This remains true even where software may have contributed to this faulty diagnosis. This is because in
many jurisdictions, the case law has developed in relation to software used to support rather than make clinical
decisions.”).
53
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Questions still surface when medical error arises due to malfunctions of the artificial
intelligence technology.58 Our current legal doctrines apply to the conduct of humans, so it is still
unclear as to how the doctrines will apply to artificial intelligence technology if it is functioning
in a more autonomous capacity or if the decision-making does not rest entirely in the hands of the
medical provider.59 Some argue that it is not entirely fair for providers to be solely held liable for
errors or malfunctions of artificial intelligence technology and machine learning algorithms,
especially when the technology is functioning by more autonomous means under the provider’s
supervision.60 Hence, other types of tort liability theories could be applicable to artificial
intelligence in medicine such as products liability and vicarious liability theories when a traditional
negligence framework for physician liability and medical error may not apply.61

VII. Vicarious Liability and The Use of Artificial Intelligence
One possibility is the application of the doctrine of respondeat superior to place vicarious
liability on the employer of the physician.62 If a physician is acting within the scope of his or her
employment and simultaneously commits a negligent act involving the use of artificial intelligence
technology or machine learning algorithms, then the employer of the physician can potentially be

58

Price, supra note 14, at 441.
Yavar Bathaee, The Artificial Intelligence Black Box and the Failure of Intent and Causation, 31 HARV. J.L.
TECH. 889, 894 (2018).
60
As Shailin Thomas describes in her article, there are emerging theories that if there is a decrease in associated
malpractice liability with the use of artificial intelligence and machine learning algorithms, then doctors may also be
able reduce the amount of defensive medicine that they currently practice, leading to reductions in cost in the
provision of health care. Thomas, supra note 24 (explaining that it is hoped that “as these algorithms proliferate and
improve, doctors will begin to rely on their superior accuracy and precision, and the associated decrease in
malpractice liability will allow those doctors to forego ordering every conceivable test or treatment.”).
61
Bal, supra note 46, at 345.
62
Id.; see also Sanchez v. Unified Sch. Dist., 339 P.3d 399, 407–08 (Kan. Ct. App. 2014) (“Under the doctrine of
respondeat superior, an employer may be held liable to a third person for injuries caused by the negligence of an
employee if the employee is acting within the scope of employment. An employer is generally relieved of liability
under a theory of respondeat superior when a legal or factual determination has been made that the employee did not
act negligently. Statutory immunity from liability granted by the legislature to an employee is personal to the
employee and, in the absence of a clear legislative statement to the contrary, does not shield the employer from
liability under a theory of respondeat superior.”).
59
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held liable for their wrongdoing.63 Under this theory, health care providers and hospitals may also
be held negligent for failing to properly train and/or supervise employees in the use of the artificial
intelligence technology if an error were to occur.64 It has additionally been questioned whether
health care providers and hospitals themselves must evaluate the quality of the artificial
intelligence technology and machine learning algorithms before physicians use them in the course
of treating their patients.65 Courts have not addressed this issue yet, as the technology is still
developing, and the information to make such a determination is largely unavailable at this time.66
Currently, it is still unclear how courts will apply vicarious liability doctrines to the use of artificial
intelligence in medicine.67
VIII. Products Liability Laws Applied to Artificial Intelligence
Under current products liability laws, the manufacturers and creators of the artificial
intelligence technology and machine learning algorithms that are currently being used in medicine

Id.; see also Far W. Fin. Corp. v. D & S Co., 760 P.2d 399, 410–11 (Cal. 1988) (“As a leading text on torts
explains, the modern justification for vicarious liability closely parallels the justification for imposing liability on the
nonnegligent manufacturer of a product: ‘What has emerged as the modern justification for vicarious liability is a
rule of policy, a deliberate allocation of risk. The losses caused by the torts of employees, which as a practical matter
are sure to occur in the conduct of the employer’s enterprise, are placed upon that enterprise itself, as a required cost
of doing business. They are placed upon the employer because, having engaged in an enterprise, which will on the
basis of all past experience involve harm to others through the torts of employees and sought to profit by it, it is just
that he, rather than the innocent plaintiff, should bear them; and because he is better able to absorb them, and to
distribute them, through prices, rates or liability insurance, to the public, and so to shift them to society, to the
community at large.’” (citing PROSSER & KEETON ON TORTS § 69, p. 500 (5th ed. 1984))).
64
Sullivan & Schweikart, supra note 2, at 162.
65
Price, supra note 14, at 420, 430.
66
Id. at 449 (explaining that even though the algorithms can potentially perform “the usual analyses more quickly
and cheaply” than providers could without the use of the technology, “excessive caution” will likely still be used
since courts have not tackled these issues of liability surrounding the use of artificial intelligence in medicine).
67
Id. (clarifying that questions arise when determining what healthcare providers and healthcare institutions must do
to fulfill their duties of care to patients in health care systems that use artificial intelligence technology and machine
learning algorithms. Some of these questions include: “Must providers themselves evaluate the quality of black-box
algorithms, based on procedural measures (validation undertaken, performance statistics, etc.) before relying on
those algorithms in the course of providing care? And should healthcare institutions perform similar evaluations
before implementing black-box software?” Currently, the information needed to make these types of evaluations and
answer these questions is mostly unavailable).
63
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may potentially be liable if an error involving the technology occurs.68 Liability could exist based
on the products liability principle that if the product, the artificial intelligence technology, causes
harm, then that harm is implied proof of some defect within the technology.69
The idea of imposing liability on the manufacturer is based on the reasoning that the creator
must pay for any harm caused by the technology.70 Arguably then, the creator is in the best place
to develop the artificial intelligence technology so that it is safe and will prevent harm to users.71
The creator and/or manufacturer will also be in the best position to “absorb any economic losses
stemming from the harm.”72 Medical devices and technology have at times been categorized by
courts as “unavoidably unsafe products”, meaning that they are made in a way that makes them
incapable of being completely safe.73 A negligence standard will then be applied to a design that
is considered defective under the products liability doctrines.74 This negligence standard “focuses
on the conduct of the manufacturer to use reasonable care to design…a product that is reasonably
safe.”75 The standard of “reasonable care” is then decided based on what the manufacturer knew
or reasonably should have known at the time that the plaintiff was injured by the product.76 Even

Matthew O. Wagner, You Can’t Sue a Robot: Are Existing Tort Theories Ready for Artificial Intelligence?, FROST
BROWN TODD (Feb. 7, 2018), https://www.frostbrowntodd.com/resources-you-cant-sue-a-robot-are-existing-torttheories-ready-for-artificial-intelligence.html.
69
Id.
70
Payne v. Paugh, 360 P.3d 39, 50 (Wash. App. Div. 1 2015).
71
Id.
72
Wagner, supra note 68.
73
Payne, 360 P.3d at 50.
74
Id.; see also RESTATEMENT (SECOND) OF TORTS § 402A cmt. k (AM. LAW INST. 1965) (describing the concept of
an “unavoidably safe product,” such as a medical device or a prescription drug, for purposes of product liability law
and establishes an exception to strict liability for unavoidably unsafe products).
75
Payne, 360 P.3d at 53.
76
Id. at 53–54 (determining whether a manufacturer has exercised reasonable care, the court in Payne instructed that
the trier of fact must consider that a medical device manufacturer (1) “has a duty to use reasonable care to test,
analyze, and inspect the products it sells, and is presumed to know what such tests would have revealed” and (2)
“has a duty to use reasonable care to keep abreast scientific knowledge, discoveries, advances, and research in the
field and is presumed to know what is imparted thereby.”); see also RESTATEMENT (SECOND) OF TORTS § 402A cmt.
k (AM. LAW INST. 1965) (“[A] trier of fact must consider that a medical device manufacturer (1) has a duty to use
reasonable care to test, analyze, and inspect the products it sells and is presumed to know what such tests would
have revealed and (2) has a duty to use reasonable care to keep abreast scientific knowledge, discoveries, advances,
and research in the field and is presumed to know what is imparted thereby.”).
68
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though these standards have historically been applied by courts to medical devices, prescriptions,
and their respective manufacturers, applications to artificial intelligence technology and the
machine learning algorithms currently used in medicine are feasible.77
Application of a products liability theory to artificial intelligence can be complicated. A
designer of artificial intelligence technology cannot necessarily foresee how the technology will
act once it is being used in a real world medical setting.78 Therefore, it can be unfair to assign
blame to one person whose work was far removed from the actual operation of the technology in
a medical setting.79 So many entities and individuals, such as designers, engineers, and developers,
work together to create artificial intelligence technology and systems.80 This makes it especially
difficult to blame one individual.81 Moreover, arguments have been made that applying strict
liability under traditional products liability doctrines will be too difficult since the algorithms in
the artificial intelligence technology currently being used in medicine are characteristically
imperfect.82 For example, an algorithm developed by researchers at Stanford has an accuracy rate

77

Price, supra note 21, at 457; see also Price, supra note 3, at 11.
Sullivan & Schweikart, supra note 2, at 162–63.
79
Id. at 163.
80
Id.; see also Wagner, supra note 68.
81
Sullivan & Schweikart, supra note 2, at 163; see also Wagner, supra note 68.
82
Thomas, supra note 16 (“Traditional products liability doctrine applies strict liability to most consumer products.
If a can of soda explodes and injures someone, the company that produced it is liable, even if it didn’t do anything
wrong in the manufacturing or distribution processes. Strict liability works well for most consumer products but
would likely prove too burdensome for medical algorithms. This is because medical algorithms are inherently
imperfect. No matter how good the algorithm is — or how much better it is than a human physician — it will
occasionally be wrong. Even the best algorithms will give rise to potentially substantial liability some percentage of
the time under a strict liability regime.”).
83
Id. (referring to a research study performed by researchers at Stanford who “developed an algorithm that can
diagnose melanomas as well as or better than expert dermatologists.” It is also important to note that the study
claims that “as the algorithm improves, it could become an important part of identifying melanomas as early and
often as possible.”); see also Andre Esteva et al., Dermatologist-Level Classification of Skin Cancer with Deep
Neural Networks, 542 NATURE INT’L J. SCI. 115, 115 (2017) (“Skin cancer, the most common human malignancy, is
primarily diagnosed visually, beginning with an initial clinical screening and followed potentially by dermoscopic
analysis, a biopsy and histopathological examination. Automated classification of skin lesions using images is a
challenging task owing to the fine-grained variability in the appearance of the skin lesions. Deep convolutional
neural networks (CNNs), show potential for general and highly variable tasks across many fine-grained object
categories.”).
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of less than 75%.83

Even though this technology will likely be of benefit to the medical

community, it would impose liability each time a patient is inevitably misdiagnosed based on its
accuracy rate under a strict liability theory.84 Imposing strict liability in this example would not
be beneficial since the production of this technology would likely slow down or cease completely
if such sure and immediate liability was imminent.85 This would be a setback for the medical
community since the full potential of the use of artificial intelligence technology and machine
learning algorithms would never be fully realized if development and production decreased or
stopped due to fear of the imposition of liability.86 This is why some argue that strict liability
could be avoided altogether if an “unavoidably unsafe products” approach were to be applied, as
previously mentioned.87 However, questions then arise relating to the duty to warn under an
unavoidably unsafe products approach.88 Under this approach, a manufacturer would have to rely
on a learned intermediary to warn the ultimate user of the manufacturer’s product.89 For example,
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Sullivan & Schweikart, supra note 2, at 162; see also Thomas, supra note 16.
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Sullivan & Schweikart, supra note 2, at 162; see also Conley v. Lift-All Co., No. 1:03-CV-1200-DFH-TAB, 2005
WL 1799505, at *9 (S.D. Ind. July 25, 2005) (considering RESTATEMENT (SECOND) OF TORTS § 388, cmt. n (AM.
LAW INST. 2012), in determining whether a manufacturer has satisfied a duty to warn by relying on a learned
intermediary. RESTATEMENT (SECOND) OF TORTS § 388, cmt. n (AM. LAW INST. 2012), considers the “likelihood or
unlikelihood that harm will occur if the intermediary does not pass on the warning to the ultimate user, the trivial
nature of the probable harm, the probability or improbability that the particular intermediary will not pass on the
warning, and the ease or burden of the giving of the warning by the manufacturer to the ultimate user . . . . [In
addition], the manufacturer’s reliance on the intermediary’s alleged sophistication may be more or less reasonable
given the product’s nature, complexity and associated dangers, the likelihood that the intermediary will
communicate warnings to the ultimate consumer, the dangers posed to the ultimate consumer by an inadequate or
nonexistent warning, and the feasibility of requiring the manufacturer to directly warn the product’s ultimate
consumers.”).
86

14

the manufacturer or developer of the artificial intelligence technology would need to rely on the
health care provider to warn the patient of the potential risks associated with utilizing the
technology.90 Liability for pharmaceuticals and medical device manufacturers is often determined
by utilizing this method, but it likely would not be as easily applied to the use of artificial
intelligence technology in medicine.91 First, because of the way that the artificial intelligence
technology is tested before use, all of the potential risks or complications that may arise from its
usage will likely be discovered.92 This means that the probability of an unknown error occurring
is not likely.93 Second, since the algorithms are designed to be very accurate, an unavoidably
unsafe products approach likely will not apply to the use of artificial intelligence in medicine in
the same way that it applies to medical devices or pharmaceuticals.94

IX. Summary
The use of artificial intelligence technology in a medical setting will unavoidably create
risks because not all of the possible consequences of the use of the new technology are
foreseeable.95 As discussed, there is currently limited information as to legal implications for tort
liability for error involving artificial intelligence in medical settings since the technology and usage
are still developing themselves.96

Current tort liability laws may be applicable, yet under

traditional tort liability it remains somewhat unclear as to the possible legal implications in the
event of medical error involving artificial intelligence technology and machine learning
algorithms.97
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Some argue in favor of applying the traditional tort liability theories to artificial intelligence
used in medicine since there is evidence of the “human hand” involved in machine-based decision
making.98 Under this theory, a human who helps to develop a piece of artificial intelligence
technology or helps guide its decision making is potentially “responsible for wrongful acts –
negligent or intentional – committed by, or involving, the machine.”99 This reasoning is based
upon the idea that artificial intelligence technology is not fully autonomous, so it cannot be
considered a “legal person” that may be held accountable under tort law for errors. 100 The types
of artificial intelligence used in medicine today fall within this category since the technology is
not yet fully autonomous.101 For example, an app that may aid a physician in diagnosing a patient
and the da Vinci Surgical System, previously mentioned, both function under human supervision
and with the input of data by humans.102 Artificial intelligence currently used in medicine is not
fully autonomous in the same way as artificial intelligence technology utilized by driver-less cars
or fully independent drone aircrafts.103 Therefore, it is feasible for current tort laws to be applied
to the use of artificial intelligence and machine learning algorithms currently used in medicine
since there is still evidence of the “human hand” in their usage.104 Also, current products liability
laws could potentially be applicable.105
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Vladeck, supra note 7, at 120.
Id. at 120–21.
100
Id. at 121 (explaining that despite the sophistication of artificial intelligence technology and machines, they have
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101
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However several counterarguments to this theory exist since some argue that it unfair to
assign blame to those whose work was far removed from the actual use of the artificial intelligence
technology.106 Imposing strict liability arguably would not be beneficial since the production of
the artificial intelligence technology would likely slow down or cease completely if such sure and
immediate liability was imminent under current products liability and strict liability theories.107
Many fear that this would be a setback for the medical community since the full potential of the
use of artificial intelligence technology and machine learning algorithms would never be fully
realized if development and production decreased or stopped due to fear of the imposition of
liability.108

X. Conclusion
Today, artificial intelligence and machine learning algorithms are being used in
approximately 86% of health care providers’ practices.109 Innovators began to develop these forms
of artificial intelligence technology in an effort to improve the efficiency and quality of patient
care, as well as to improve the cost and access to care while at the same time advancing medical
research.110 Artificial intelligence technology already does aid in improving the quality and access
to health care and has the potential to continue to provide significant developments in the field of
medicine; however, this substantial potential comes with medical, technical, and legal
challenges.111
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Concerns arise when questioning how safe and effective artificial intelligence in medicine
will be, and the issue then becomes how to protect and provide recourse to patients.112 Current tort
liability theories may be applicable, but information at this time is largely unavailable to make
evaluations of how exactly how these theories will apply.113 Courts have also not yet addressed
many of the issues surrounding liability and the usage of artificial intelligence technology and
machine learning algorithms in medicine.114 In the future the goal will become ensuring the
efficient development and continuing use of artificial intelligence technology in medicine, but
these developments may change the way current laws are applied in the context of contemporary
health care liability issues.115 As artificial intelligence technology continues to develop, courts
will need to address these potential disputes surrounding the usage of artificial intelligence in
medicine, and the need for the consideration of issues will likely grow in the future.116
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